Cassava Sciences Newsroom

H.C. Wainwright Upgrades Cassava Sciences(SAVA.US) to Buy Rating, Announces Target Price $116

Moomoo NewsOct 8 08:33 ET

Cassava Sciences Price Target Announced at $116.00/Share by HC Wainwright & Co.

Dow JonesOct 8 08:29 ET

Cassava Sciences Analyst Ratings

BenzingaOct 8 08:19 ET

Cassava Sciences Upgraded to Buy From Neutral at H.C. Wainwright

TipRanksOct 8 08:12 ET

Cassava Sciences Analyst Ratings

BenzingaAug 13 07:22 ET

H.C. Wainwright Maintains Cassava Sciences(SAVA.US) With Hold Rating

Moomoo NewsAug 13 06:31 ET

JonesTrading Keeps Their Hold Rating on Cassava Sciences (SAVA)

TipRanksAug 8 17:03 ET

Cassava Sciences Analyst Ratings

BenzingaAug 8 14:28 ET

Cassava Sciences Analyst Ratings

BenzingaJul 19 06:44 ET

H.C. Wainwright Sticks to Their Hold Rating for Cassava Sciences (SAVA)

TipRanksJul 19 06:22 ET

Cassava Sciences Analyst Ratings

BenzingaJul 1 07:04 ET

Cassava Sciences (SAVA) Was Downgraded to a Hold Rating at H.C. Wainwright

TipRanksJul 1 06:18 ET

Analysts Offer Insights on Healthcare Companies: Aroa Biosurgery Ltd (AU:ARX), Cassava Sciences (SAVA) and Amplifon S.p.A. (GB:0N61)

TipRanksMay 27 05:05 ET

Cassava Sciences Analyst Ratings

BenzingaMay 17 08:12 ET

Cassava Sciences Progresses in Phase 3 Trials, Secures Strong Cash Position: A Buy Rating Justified

TipRanksMay 13 16:30 ET

Cassava Sciences Analyst Ratings

BenzingaMar 5 06:44 ET

Analysts Are Bullish on These Healthcare Stocks: Cassava Sciences (SAVA), Repare Therapeutics (RPTX)

TipRanksFeb 28 14:50 ET

Analysts Are Bullish on These Healthcare Stocks: Cassava Sciences (SAVA), CymaBay Therapeutics (CBAY)

TipRanksNov 8, 2023 09:10 ET

Analysts Offer Insights on Healthcare Companies: Cassava Sciences (SAVA), Kiora Pharmaceuticals (KPRX) and Bluebird Bio (BLUE)

TipRanksNov 7, 2023 11:31 ET

Cassava Sciences' Simufilam Efficacy and Safety in Alzheimer's Treatment Bolsters Buy Rating: An Analysis of Trial Results and Future Projections

TipRanksOct 30, 2023 12:25 ET